1. Brunel University Research Archive
  2. College of Health, Medicine and Life Sciences
  3. Dept of Health Sciences
  4. Dept of Health Sciences Research Papers
Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/24737
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPerez, GF-
dc.contributor.authorShieh, P-
dc.contributor.authorKuntz, N-
dc.contributor.authorDowling, J-
dc.contributor.authorMueller-Felber, W-
dc.contributor.authorBlaschek, A-
dc.contributor.authorBonnemann, C-
dc.contributor.authorFoley, A-
dc.contributor.authorSaade, D-
dc.contributor.authorSeferian, A-
dc.contributor.authorServais, L-
dc.contributor.authorLawlor, M-
dc.contributor.authorMacBean, V-
dc.contributor.authorCoats, J-
dc.contributor.authorHan, C-
dc.contributor.authorLee, J-
dc.contributor.authorNoursalehi, M-
dc.contributor.authorPrasad, S-
dc.contributor.authorRico, S-
dc.contributor.authorMiller, W-
dc.contributor.authorGraham, R-
dc.date.accessioned2022-06-28T12:25:28Z-
dc.date.available2022-06-28T12:25:28Z-
dc.date.issued2022-05-01-
dc.identifierA3003-
dc.identifier.citationPerez, G.F., Shieh, P., Kuntz, N., Dowling, J.J., Müller-Felber, W., Blaschek, A., Bönnemann, C., Foley, A.R., Saade, D., Seferian, A.M.S., Servais, V., Lawlor, M., MacBean, V., Coats J.,Han C., Lee J., Noursalehi M., Prasad S., Rico, S., Miller, W. and Graham, R.J. (2022) 'Improved Respiratory Outcomes for X-Linked Myotubular Myopathy (XLMTM) with Gene Replacement Therapy, Resamirigene Bilparvovec (ASPIRO): Preliminary Results from ASPIRO, a Phase 1/2/3 Study', American Journal of Respiratory and Critical Care Medicine, 205, A3003, pp. 1-3. doi: 10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3003.en_US
dc.identifier.issn1073-449X-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/24737-
dc.description.sponsorshipAstelas Gene Therapies.en_US
dc.format.extent1 - 3-
dc.format.mediumPrint-Electronic-
dc.language.isoen_USen_US
dc.titleImproved Respiratory Outcomes for X-Linked Myotubular Myopathy (XLMTM) with Gene Replacement Therapy, Resamirigene Bilparvovec (ASPIRO): Preliminary Results from ASPIRO, a Phase 1/2/3 Studyen_US
dc.typeConference Paperen_US
dc.identifier.doihttps://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3003-
dc.relation.isPartOfAmerican Journal of Respiratory and Critical Care Medicine-
pubs.publication-statusPublished-
pubs.volume205-
dc.identifier.eissn1535-4970-
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
MeetingAbstract.pdf129.71 kBAdobe PDFView/Open
Show simple item record


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.